Added to YB: 2023-07-18
Pitch date: 2023-07-18
VIRX [bullish]
Viracta Therapeutics, Inc.
-99.33%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide.
Market Cap
$765.1K
Pitch Price
$1.47
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.07
P/E
-0.02
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
VIRACTA THERAPEUTICS INC VIRX
A summary for this pitch has not been created yet.
Read full article (0 min)